Two cases of recurrent priapism during antineoplastic chemotherapy: think about ondansetron.
Regional Pharmacovigilance Center, University Hospital of Nancy, Nancy, France.
Diane
D
Pivot
Regional Pharmacovigilance Center, University Hospital of Nancy, Nancy, France.
Lucie
L
Javot
Regional Pharmacovigilance Center, University Hospital of Nancy, Nancy, France.
Dominique
D
Swiegot
Regional Pharmacovigilance Center, University Hospital of Nancy, Nancy, France.
Nadine
N
Petitpain
Clinic of Gentilly, Department of Oncology, Nancy, France.
Dominique
D
Spaëth
Department of Clinical PharmacologyUniversity Hospital of Nancy, Nancy, France.
Philippe
P
Trechot
D000368:Aged; D000932:Antiemetics / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017294:Ondansetron / Q000009:adverse effects* / Q000627:therapeutic use; D011317:Priapism / Q000139:chemically induced*; D012008:Recurrence; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use
D000932:Antiemetics; D000970:Antineoplastic Agents; D012702:Serotonin Antagonists; D017294:Ondansetron